UCP2 and colorectal carcinoma: Recently, Aguilar et al. demonstrated that although UCP2 expression was higher in murine colorectal cancer (CRC) compared to normal tissue, its deletion enhanced colon and small intestinal tumorigenesis in carcinogen-induced and ApcMin/+ mice models, respectively.